Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Fusion Transcript Assays Market Research Report 2026

Global Fusion Transcript Assays Market Research Report 2026

Industry: Medical Devices & Consumables

Published Date: 2026-04-17

Pages: 107 Pages

Report ld: 6467451

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Fusion Transcript Assays Market Size(US$)

CAGR 2026-2032

3.6%

Market Size,2032

USD 123

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 99 million

Market Forecast in 2032(Value)

US$ 123 million

CAGR

3.6%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Fusion Transcript Assays market was valued at US$ 96 million in 2025 and is anticipated to reach US$ 123 million by 2032, at a CAGR of 3.6% from 2026 to 2032.

The North American market for Fusion Transcript Assays is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Fusion Transcript Assays is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Fusion Transcript Assays in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Fusion Transcript Assays include Thermo Fisher Scientific, Illumina, Inc., Merck Millipore, Hologic Inc., Hologic Inc Bio-Rad Laboratories Inc., Caris Life Sciences, SeraCare Life Sciences Inc., QIAGEN, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Fusion Transcript Assays market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Fusion Transcript Assays. The Fusion Transcript Assays market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Fusion Transcript Assays market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Fusion Transcript Assays manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Thermo Fisher Scientific
Illumina, Inc.
Merck Millipore
Hologic Inc.
Hologic Inc Bio-Rad Laboratories Inc.
Caris Life Sciences
SeraCare Life Sciences Inc.
QIAGEN

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Fusion Transcript Kits
PCR Devices

Segment by Application

Hospital
Cancer Research Center
Diagnostic Laboratory
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Fusion Transcript Assays companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Fusion Transcript Assays Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Fusion Transcript Kits

1.2.3 PCR Devices

1.3 Market by Application

1.3.1 Global Fusion Transcript Assays Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Cancer Research Center

1.3.4 Diagnostic Laboratory

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Fusion Transcript Assays Market Perspective (2021–2032)

2.2 Global Fusion Transcript Assays Growth Trends by Region

2.2.1 Global Fusion Transcript Assays Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Fusion Transcript Assays Historic Market Size by Region (2021–2026)

2.2.3 Fusion Transcript Assays Forecasted Market Size by Region (2027–2032)

2.3 Fusion Transcript Assays Market Dynamics

2.3.1 Fusion Transcript Assays Industry Trends

2.3.2 Fusion Transcript Assays Market Drivers

2.3.3 Fusion Transcript Assays Market Challenges

2.3.4 Fusion Transcript Assays Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Fusion Transcript Assays Players by Revenue

3.1.1 Global Top Fusion Transcript Assays Players by Revenue (2021–2026)

3.1.2 Global Fusion Transcript Assays Revenue Market Share by Players (2021–2026)

3.2 Global Top Fusion Transcript Assays Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Fusion Transcript Assays Revenue

3.4 Global Fusion Transcript Assays Market Concentration Ratio

3.4.1 Global Fusion Transcript Assays Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fusion Transcript Assays Revenue in 2025

3.5 Global Key Players of Fusion Transcript Assays Head Offices and Areas Served

3.6 Global Key Players of Fusion Transcript Assays, Products and Applications

3.7 Global Key Players of Fusion Transcript Assays, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Fusion Transcript Assays Breakdown Data by Type

4.1 Global Fusion Transcript Assays Historic Market Size by Type (2021–2026)

4.2 Global Fusion Transcript Assays Forecasted Market Size by Type (2027–2032)

5 Fusion Transcript Assays Breakdown Data by Application

5.1 Global Fusion Transcript Assays Historic Market Size by Application (2021–2026)

5.2 Global Fusion Transcript Assays Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Fusion Transcript Assays Market Size (2021–2032)

6.2 North America Fusion Transcript Assays Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Fusion Transcript Assays Market Size by Country (2021–2026)

6.4 North America Fusion Transcript Assays Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Fusion Transcript Assays Market Size (2021–2032)

7.2 Europe Fusion Transcript Assays Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Fusion Transcript Assays Market Size by Country (2021–2026)

7.4 Europe Fusion Transcript Assays Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Fusion Transcript Assays Market Size (2021–2032)

8.2 Asia-Pacific Fusion Transcript Assays Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Fusion Transcript Assays Market Size by Region (2021–2026)

8.4 Asia-Pacific Fusion Transcript Assays Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Fusion Transcript Assays Market Size (2021–2032)

9.2 Latin America Fusion Transcript Assays Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Fusion Transcript Assays Market Size by Country (2021–2026)

9.4 Latin America Fusion Transcript Assays Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Fusion Transcript Assays Market Size (2021–2032)

10.2 Middle East & Africa Fusion Transcript Assays Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Fusion Transcript Assays Market Size by Country (2021–2026)

10.4 Middle East & Africa Fusion Transcript Assays Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Fusion Transcript Assays Introduction

11.1.4 Thermo Fisher Scientific Revenue in Fusion Transcript Assays Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Illumina, Inc.

11.2.1 Illumina, Inc. Company Details

11.2.2 Illumina, Inc. Business Overview

11.2.3 Illumina, Inc. Fusion Transcript Assays Introduction

11.2.4 Illumina, Inc. Revenue in Fusion Transcript Assays Business (2021–2026)

11.2.5 Illumina, Inc. Recent Development

11.3 Merck Millipore

11.3.1 Merck Millipore Company Details

11.3.2 Merck Millipore Business Overview

11.3.3 Merck Millipore Fusion Transcript Assays Introduction

11.3.4 Merck Millipore Revenue in Fusion Transcript Assays Business (2021–2026)

11.3.5 Merck Millipore Recent Development

11.4 Hologic Inc.

11.4.1 Hologic Inc. Company Details

11.4.2 Hologic Inc. Business Overview

11.4.3 Hologic Inc. Fusion Transcript Assays Introduction

11.4.4 Hologic Inc. Revenue in Fusion Transcript Assays Business (2021–2026)

11.4.5 Hologic Inc. Recent Development

11.5 Hologic Inc Bio-Rad Laboratories Inc.

11.5.1 Hologic Inc Bio-Rad Laboratories Inc. Company Details

11.5.2 Hologic Inc Bio-Rad Laboratories Inc. Business Overview

11.5.3 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Introduction

11.5.4 Hologic Inc Bio-Rad Laboratories Inc. Revenue in Fusion Transcript Assays Business (2021–2026)

11.5.5 Hologic Inc Bio-Rad Laboratories Inc. Recent Development

11.6 Caris Life Sciences

11.6.1 Caris Life Sciences Company Details

11.6.2 Caris Life Sciences Business Overview

11.6.3 Caris Life Sciences Fusion Transcript Assays Introduction

11.6.4 Caris Life Sciences Revenue in Fusion Transcript Assays Business (2021–2026)

11.6.5 Caris Life Sciences Recent Development

11.7 SeraCare Life Sciences Inc.

11.7.1 SeraCare Life Sciences Inc. Company Details

11.7.2 SeraCare Life Sciences Inc. Business Overview

11.7.3 SeraCare Life Sciences Inc. Fusion Transcript Assays Introduction

11.7.4 SeraCare Life Sciences Inc. Revenue in Fusion Transcript Assays Business (2021–2026)

11.7.5 SeraCare Life Sciences Inc. Recent Development

11.8 QIAGEN

11.8.1 QIAGEN Company Details

11.8.2 QIAGEN Business Overview

11.8.3 QIAGEN Fusion Transcript Assays Introduction

11.8.4 QIAGEN Revenue in Fusion Transcript Assays Business (2021–2026)

11.8.5 QIAGEN Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Fusion Transcript Assays Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Fusion Transcript Kits

Table 3. Key Players of PCR Devices

Table 4. Global Fusion Transcript Assays Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Fusion Transcript Assays Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Fusion Transcript Assays Market Size by Region (US$ Million), 2021–2026

Table 7. Global Fusion Transcript Assays Market Share by Region (2021–2026)

Table 8. Global Fusion Transcript Assays Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Fusion Transcript Assays Market Share by Region (2027–2032)

Table 10. Fusion Transcript Assays Market Trends

Table 11. Fusion Transcript Assays Market Drivers

Table 12. Fusion Transcript Assays Market Challenges

Table 13. Fusion Transcript Assays Market Restraints

Table 14. Global Fusion Transcript Assays Revenue by Players (US$ Million), 2021–2026

Table 15. Global Fusion Transcript Assays Market Share by Players (2021–2026)

Table 16. Global Top Fusion Transcript Assays Players by Tier (Tier 1, Tier 2, and Tier 3), based on Fusion Transcript Assays Revenue, 2025

Table 17. Ranking of Global Top Fusion Transcript Assays Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Fusion Transcript Assays Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Fusion Transcript Assays, Headquarters and Area Served

Table 20. Global Key Players of Fusion Transcript Assays, Products and Applications

Table 21. Global Key Players of Fusion Transcript Assays, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Fusion Transcript Assays Market Size by Type (US$ Million), 2021–2026

Table 24. Global Fusion Transcript Assays Revenue Market Share by Type (2021–2026)

Table 25. Global Fusion Transcript Assays Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Fusion Transcript Assays Revenue Market Share by Type (2027–2032)

Table 27. Global Fusion Transcript Assays Market Size by Application (US$ Million), 2021–2026

Table 28. Global Fusion Transcript Assays Revenue Market Share by Application (2021–2026)

Table 29. Global Fusion Transcript Assays Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Fusion Transcript Assays Revenue Market Share by Application (2027–2032)

Table 31. North America Fusion Transcript Assays Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Fusion Transcript Assays Market Size by Country (US$ Million), 2021–2026

Table 33. North America Fusion Transcript Assays Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Fusion Transcript Assays Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Fusion Transcript Assays Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Fusion Transcript Assays Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Fusion Transcript Assays Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Fusion Transcript Assays Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Fusion Transcript Assays Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Fusion Transcript Assays Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Fusion Transcript Assays Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Fusion Transcript Assays Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Fusion Transcript Assays Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Fusion Transcript Assays Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Fusion Transcript Assays Market Size by Country (US$ Million), 2027–2032

Table 46. Thermo Fisher Scientific Company Details

Table 47. Thermo Fisher Scientific Business Overview

Table 48. Thermo Fisher Scientific Fusion Transcript Assays Product

Table 49. Thermo Fisher Scientific Revenue in Fusion Transcript Assays Business (US$ Million), 2021–2026

Table 50. Thermo Fisher Scientific Recent Development

Table 51. Illumina, Inc. Company Details

Table 52. Illumina, Inc. Business Overview

Table 53. Illumina, Inc. Fusion Transcript Assays Product

Table 54. Illumina, Inc. Revenue in Fusion Transcript Assays Business (US$ Million), 2021–2026

Table 55. Illumina, Inc. Recent Development

Table 56. Merck Millipore Company Details

Table 57. Merck Millipore Business Overview

Table 58. Merck Millipore Fusion Transcript Assays Product

Table 59. Merck Millipore Revenue in Fusion Transcript Assays Business (US$ Million), 2021–2026

Table 60. Merck Millipore Recent Development

Table 61. Hologic Inc. Company Details

Table 62. Hologic Inc. Business Overview

Table 63. Hologic Inc. Fusion Transcript Assays Product

Table 64. Hologic Inc. Revenue in Fusion Transcript Assays Business (US$ Million), 2021–2026

Table 65. Hologic Inc. Recent Development

Table 66. Hologic Inc Bio-Rad Laboratories Inc. Company Details

Table 67. Hologic Inc Bio-Rad Laboratories Inc. Business Overview

Table 68. Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Product

Table 69. Hologic Inc Bio-Rad Laboratories Inc. Revenue in Fusion Transcript Assays Business (US$ Million), 2021–2026

Table 70. Hologic Inc Bio-Rad Laboratories Inc. Recent Development

Table 71. Caris Life Sciences Company Details

Table 72. Caris Life Sciences Business Overview

Table 73. Caris Life Sciences Fusion Transcript Assays Product

Table 74. Caris Life Sciences Revenue in Fusion Transcript Assays Business (US$ Million), 2021–2026

Table 75. Caris Life Sciences Recent Development

Table 76. SeraCare Life Sciences Inc. Company Details

Table 77. SeraCare Life Sciences Inc. Business Overview

Table 78. SeraCare Life Sciences Inc. Fusion Transcript Assays Product

Table 79. SeraCare Life Sciences Inc. Revenue in Fusion Transcript Assays Business (US$ Million), 2021–2026

Table 80. SeraCare Life Sciences Inc. Recent Development

Table 81. QIAGEN Company Details

Table 82. QIAGEN Business Overview

Table 83. QIAGEN Fusion Transcript Assays Product

Table 84. QIAGEN Revenue in Fusion Transcript Assays Business (US$ Million), 2021–2026

Table 85. QIAGEN Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Fusion Transcript Assays Picture

Figure 2. Global Fusion Transcript Assays Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Fusion Transcript Assays Market Share by Type: 2025 vs 2032

Figure 4. Fusion Transcript Kits Features

Figure 5. PCR Devices Features

Figure 6. Global Fusion Transcript Assays Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Fusion Transcript Assays Market Share by Application: 2025 vs 2032

Figure 8. Hospital Case Studies

Figure 9. Cancer Research Center Case Studies

Figure 10. Diagnostic Laboratory Case Studies

Figure 11. Others Case Studies

Figure 12. Fusion Transcript Assays Report Years Considered

Figure 13. Global Fusion Transcript Assays Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Fusion Transcript Assays Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Fusion Transcript Assays Market Share by Region: 2025 vs 2032

Figure 16. Global Fusion Transcript Assays Market Share by Players in 2025

Figure 17. Global Fusion Transcript Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Fusion Transcript Assays Revenue in 2025

Figure 19. North America Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Fusion Transcript Assays Market Share by Country (2021–2032)

Figure 21. United States Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Fusion Transcript Assays Market Share by Country (2021–2032)

Figure 25. Germany Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Fusion Transcript Assays Market Share by Region (2021–2032)

Figure 33. China Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Fusion Transcript Assays Market Share by Country (2021–2032)

Figure 41. Mexico Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Fusion Transcript Assays Market Share by Country (2021–2032)

Figure 45. Israel Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Fusion Transcript Assays Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Fusion Transcript Assays Business (2021–2026)

Figure 49. Illumina, Inc. Revenue Growth Rate in Fusion Transcript Assays Business (2021–2026)

Figure 50. Merck Millipore Revenue Growth Rate in Fusion Transcript Assays Business (2021–2026)

Figure 51. Hologic Inc. Revenue Growth Rate in Fusion Transcript Assays Business (2021–2026)

Figure 52. Hologic Inc Bio-Rad Laboratories Inc. Revenue Growth Rate in Fusion Transcript Assays Business (2021–2026)

Figure 53. Caris Life Sciences Revenue Growth Rate in Fusion Transcript Assays Business (2021–2026)

Figure 54. SeraCare Life Sciences Inc. Revenue Growth Rate in Fusion Transcript Assays Business (2021–2026)

Figure 55. QIAGEN Revenue Growth Rate in Fusion Transcript Assays Business (2021–2026)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.6% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Fusion Transcript Assays in 2026? shouQi

Which companies rank high in the global Fusion Transcript Assays market? shouQi

What is the annual compound growth rate of the global Fusion Transcript Assays market size from 2026 to 2032? shouQi

What was the global market size of Fusion Transcript Assays in 2032? shouQi

Related Reports

Fusion Transcript Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fusion Transcript Assays was estimated to be worth US$ 96 million in 2025 and is projected to reach US$ 123 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 106
USD 3950.00
(Single User License)
Global Fusion Transcript Assays Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fusion Transcript Assays market size was US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Global Fusion Transcript Assays Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Fusion Transcript Assays market is projected to grow from US$ 93 million in 2024 to US$ 119 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 117
USD 4900.00
(Single User License)
Fusion Transcript Assays- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Fusion Transcript Assays was estimated to be worth US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 100
USD 3950.00
(Single User License)
Global Fusion Transcript Assays Market Research Report 2025
The global market for Fusion Transcript Assays was valued at US$ 93 million in the year 2024 and is projected to reach a revised size of US$ 119 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published Date: 2025-01-13
Pages: 73
USD 2900.00
(Single User License)

Fusion Transcript Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fusion Transcript Assays was estimated to be worth US$ 96 million in 2025 and is projected to reach US$ 123 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 106
USD 3950.00 (Single User License)
Global Fusion Transcript Assays Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fusion Transcript Assays market size was US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)
Global Fusion Transcript Assays Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Fusion Transcript Assays market is projected to grow from US$ 93 million in 2024 to US$ 119 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 117
USD 4900.00 (Single User License)
Fusion Transcript Assays- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Fusion Transcript Assays was estimated to be worth US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 100
USD 3950.00 (Single User License)
Global Fusion Transcript Assays Market Research Report 2025
The global market for Fusion Transcript Assays was valued at US$ 93 million in the year 2024 and is projected to reach a revised size of US$ 119 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-01-13
Pages: 73
USD 2900.00 (Single User License)